Similar Articles
861 Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
862 Usefulness of the MESH score in a European hepatocellular carcinoma cohort
863 Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
864 Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma
865 Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
866 Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
867 Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
868 Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
869 Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
870 Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA